BEKE-W (02423) repurchased approximately 431,800 shares for approximately US$2.5 million on October 28.
BEKE-W (02423) announced that on October 28, 2026, the company repurchased approximately 431,800 shares for approximately US$2.5 million at a repurchase price of US$5.75 to US$5.89 per share.
BEKE-W (02423) announced that on October 28, 2026, the company repurchased approximately 431,800 shares for approximately US$2.5 million, at a repurchase price of US$5.75 to US$5.89 per share.
Related Articles
Victory Giant Technology (02476) plans to make additional investments of no more than US$800 million and US$700 million in its wholly-owned indirect subsidiaries Victory Giant Technology (Thailand) and Victory Giant Technology (Vietnam), respectively.
MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. reported a net profit attributable to shareholders of RMB449 million for the first three quarters, up 4.55% year on year.
KEYMED BIO-B (02162) intends to purchase shares under the 2022 Restricted Share Unit Plan.
Victory Giant Technology (02476) plans to make additional investments of no more than US$800 million and US$700 million in its wholly-owned indirect subsidiaries Victory Giant Technology (Thailand) and Victory Giant Technology (Vietnam), respectively.
MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. reported a net profit attributable to shareholders of RMB449 million for the first three quarters, up 4.55% year on year.
KEYMED BIO-B (02162) intends to purchase shares under the 2022 Restricted Share Unit Plan.
